Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjun Bao

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|May 28, 2011
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasisAlexa Boer Kimball, Andrew P Yu, James Signorovitch, et al.
Journal of the Neurological Sciences|January 1, 2021
Disease course and treatment patterns in progressive supranuclear palsy: A real-world studyJohn C Morgan, Xiaolan Ye, Jennifer A Mellor, et al.
Journal of the American Academy of Dermatology|October 12, 2010
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trialKristian Reich, James Signorovitch, Karthik Ramakrishnan, et al.
Light, Science & Applications|November 1, 2019
Full-colour nanoprint-hologram synchronous metasurface with arbitrary hue-saturation-brightness controlYanjun Bao, Ying Yu, Haofei Xu, et al.
Journal of the American Academy of Dermatology|January 17, 2012
Risks of developing psychiatric disorders in pediatric patients with psoriasisAlexa B Kimball, Eric Q Wu, Annie Guérin, et al.
Parkinsonism & Related Disorders|April 15, 2021
Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysisDavid G Standaert, Vardhaman Patel, Sonya J Snedecor, et al.
Nano Letters|November 14, 2023
Light-Emitting Microfibers from Lotus Root for Eco-Friendly Optical Waveguides and BiosensingXianguang Yang, Liping Xu, Shijie Xiong, et al.
Dermatology (Basel, Switzerland)|February 5, 2010
High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practiceJean-Hilaire Saurat, Annie Guérin, Andrew P Yu, et al.
Advances in Therapy|July 31, 2012
Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritisYifei Liu, Eric Q Wu, Arielle G Bensimon, et al.
Pharmacoeconomics|September 14, 2010
Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanerceptJames E Signorovitch, Eric Q Wu, Andrew P Yu, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|May 28, 2011
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasisAlexa Boer Kimball, Andrew P Yu, James Signorovitch, et al.
Journal of the Neurological Sciences|January 1, 2021
Disease course and treatment patterns in progressive supranuclear palsy: A real-world studyJohn C Morgan, Xiaolan Ye, Jennifer A Mellor, et al.
Journal of the American Academy of Dermatology|October 12, 2010
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trialKristian Reich, James Signorovitch, Karthik Ramakrishnan, et al.
Light, Science & Applications|November 1, 2019
Full-colour nanoprint-hologram synchronous metasurface with arbitrary hue-saturation-brightness controlYanjun Bao, Ying Yu, Haofei Xu, et al.
Journal of the American Academy of Dermatology|January 17, 2012
Risks of developing psychiatric disorders in pediatric patients with psoriasisAlexa B Kimball, Eric Q Wu, Annie Guérin, et al.
Parkinsonism & Related Disorders|April 15, 2021
Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysisDavid G Standaert, Vardhaman Patel, Sonya J Snedecor, et al.
Nano Letters|November 14, 2023
Light-Emitting Microfibers from Lotus Root for Eco-Friendly Optical Waveguides and BiosensingXianguang Yang, Liping Xu, Shijie Xiong, et al.
Dermatology (Basel, Switzerland)|February 5, 2010
High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practiceJean-Hilaire Saurat, Annie Guérin, Andrew P Yu, et al.
Advances in Therapy|July 31, 2012
Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritisYifei Liu, Eric Q Wu, Arielle G Bensimon, et al.
Pharmacoeconomics|September 14, 2010
Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanerceptJames E Signorovitch, Eric Q Wu, Andrew P Yu, et al.
Pageof 8